Frailty phenotype transitions and functional improvements during a supervised exercise trial in older people with HIV: results from the HEALTH Trial
Clicks: 20
ID: 319875
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
5.7
/100
20 views
9 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #18 of 50 articles by views in age and ageing
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background Frailty and sarcopenia contribute to functional decline in older people with HIV (PWH), yet intervention data remain limited. We evaluated changes in frailty phenotype status, sarcopenia-related outcomes and functional performance during a supervised exercise trial and assessed associations between baseline frailty, study withdrawal and intervention response. Methods The High-Intensity Exercise to Attenuate Limitations and Train Habits in Older Adults with HIV (HEALTH) study randomised sedentary PWH aged ≥50 years to 16 weeks of supervised high-intensity interval training (HIIT) or continuous moderate exercise (CME), both combined with progressive resistance training. Frailty was assessed using Fried’s phenotype; sarcopenia using current consensus definitions and exploratory HIV-specific cut-points. Functional outcomes included 400-m walk performance and fatigue. Results Of 118 participants (median age 58 years; 85% male), 94 completed the intervention. Among completers, pre-frailty/frailty status decreased from 48.9% to 30.9% (P < .01), largely reflecting improvements in exhaustion and low activity, with no significant differences between HIIT and CME. Sarcopenia prevalence was low at baseline and changed minimally across definitions. Participants with baseline pre-frailty/frailty were more likely to withdraw (P = .03), yet among retained participants demonstrated greater improvements in 400-m walk performance than non-frail participants (−7.1% [95%CI −8.7, −5.4] vs −4.6% [95% CI −6.3, −2.8]). Fatigue improved among participants with baseline pre-frailty/frailty (−3.3 points [95% CI −5.7, −0.9]) but not in non-frail participants (−1.0 points [95% CI −3.4, 1.4]). Conclusions During this supervised exercise trial, favourable frailty phenotype transitions and functional improvements were observed among older PWH, particularly in participants with baseline pre-frailty/frailty. Low sarcopenia prevalence limited conclusions regarding categorical sarcopenia outcomes. Strategies to improve retention among more vulnerable participants may enhance intervention reach and impact.
| Reference Key |
openalex_W7167497760
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Vitor H. F. Oliveira, Andre P dos Santos, Grace L. Kulik, Christine Horvat Davey, Evelyn Iriarte, Raymond C. F. Jones, Melissa P. Wilson, Vincent Khuu, Debashis Ghosh, Samantha MaWhinney, Catherine M Jankowski, Paul Cook, Kristine M Erlandson, Allison R Webel |
| Journal | age and ageing |
| Year | 2026 |
| DOI |
10.1093/ageing/afag199
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.